How should a false positive troponin (troponin) I result be approached in a patient with a history of cardiac disease and symptoms such as chest pain or shortness of breath?

Approach to False Positive Troponin I

In a patient with cardiac history and symptoms, never assume troponin elevation is false-positive until you have systematically excluded life-threatening conditions (aortic dissection, pulmonary embolism) and true myocardial injury from non-ACS causes, then confirmed analytical interference through serial measurements, alternative assays, and laboratory techniques. 1, 2

Initial Critical Exclusions

Rule Out Immediately Life-Threatening Mimics

• Aortic dissection must be excluded first - troponin elevation occurs in 23-27% of cases due to coronary ostial involvement, hemodynamic stress, or cardiac tamponade, not analytical interference 2
• Assess for tearing/ripping chest pain radiating to back, blood pressure differential between arms, new aortic regurgitation murmur, pulse deficits, or neurological deficits 2
• Pulmonary embolism also causes true troponin elevation and presents with chest pain - always consider in differential 1, 2
• Never proceed with anticoagulation or fibrinolysis until dissection is excluded, as this would be catastrophic 2

Establish True Myocardial Injury Pattern

• Obtain serial troponin measurements at 0 and 6-12 hours - a dynamic rise and fall pattern indicates acute coronary syndrome, while persistently stable elevations suggest chronic injury or interference 3, 1
• In 10-15% of patients, initial troponin may be negative, requiring repeat testing 1
• Any elevation above 99th percentile reflects irreversible myocardial cellular necrosis when measured with high-sensitivity assays 1

Non-ACS Causes of True Troponin Elevation

Cardiac Causes

• Myocarditis, heart failure exacerbation, tachyarrhythmias, hypertensive emergency, Takotsubo syndrome 1, 4
• Cardiac surgery, cardioversion, pericarditis 5

Systemic Causes

• Renal dysfunction - impaired clearance leads to higher baseline levels reflecting ongoing subclinical damage from volume overload, hypertension, or left ventricular hypertrophy 1
• Sepsis, stroke, pulmonary embolism 1, 5, 4

Confirming Analytical Interference

Clinical Red Flags for False-Positive

• Persistently elevated troponin with minimal or no symptoms over multiple presentations 6
• Troponin elevation that remains stable without dynamic changes despite repeated measurements 6, 7
• Normal CK-MB, normal ECG, and normal coronary anatomy on catheterization or CT angiography 6
• Clinical picture completely inconsistent with degree of troponin elevation 5, 7

Laboratory Confirmation Algorithm

Step 1: Exclude Preanalytical Factors

• Rule out sample mislabeling, fibrin clots, or hemolysis 8
• Repeat measurement to confirm result 8, 7

Step 2: Alternative Assay Testing

• Send sample to different laboratory using alternative immunoassay method - ideally high-sensitivity troponin I if original was troponin T 6, 8, 7
• High-sensitivity troponin T (hs-cTnT) is elevated in up to two-thirds of patients with skeletal muscle disease, while hs-cTnI remains largely unaffected 8
• If alternative assay shows zero or normal result, analytical interference is confirmed 6, 7

Step 3: Specific Interference Testing

• Perform serial dilutions (2:1,4:1) - true troponin should dilute proportionally, interference may not 6, 7
• Test for heterophile antibodies and rheumatoid factor 6, 5, 7
• Use heterophile-blocking reagents 8, 7
• Polyethylene glycol precipitation to screen for macrotroponins 8, 7
• Antibody-binding tubes to remove interfering immunoglobulins 7

Step 4: Advanced Confirmatory Techniques

• Gel filtration chromatography or immunoglobulin depletion (protein A/G) where available 8

Common Interference Mechanisms

Immunoassay Interferences

• Heterophile antibodies - human anti-animal antibodies that cross-react with assay reagents 5, 4
• Anti-troponin autoantibodies 8, 4
• Macrotroponins - troponin bound to immunoglobulins forming high-molecular-weight complexes with delayed clearance 8, 4
• Fibrin strands interfering with immunoassay 1, 4

Skeletal Muscle Disease

• High-sensitivity troponin T shows limited cardiac specificity in myopathies, while troponin I remains specific 8
• Consider switching to hs-cTnI assay in patients with known skeletal muscle disease 8

Practical Management Approach

When Interference is Suspected

• Document confirmed interference clearly in medical record to prevent future misdiagnosis 8
• Specify which assay showed interference and which alternative assay is reliable for future testing 8
• Avoid unnecessary cardiac catheterization, which carries procedural risk 6

Risk Stratification Context

• Never use troponin alone - international guidelines strongly recommend against using high-sensitivity troponin measured at 0 and 2 hours alone to exclude ACS 3
• Combine with clinical risk scores (TIMI score 0-1, Vancouver rule, HEART score, North American CP rule) for safe discharge decisions 3
• False-negative rates range from 0-7.8% depending on assay and clinical scoring used 3

Future Considerations

• Prevalence of analytical interference likely to increase due to emergence of immunotherapy and radiolabeled antibodies in diagnosis 6, 4
• Maintain high index of suspicion when clinical picture doesn't match laboratory results 5, 7, 4